Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Norris Medicines
|
Parmax Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | 47.03 % | -1624.87 % |
|
5yr Avg Net Profit Margin
|
-0.06 % | -30.66 % | -9.48 % |
|
Price to Book
|
1.18 | 0.0 | 0.0 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | 97.28 Days | -161.05 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | -1.37 | 1.16 |
|
5yr Avg ROCE
|
5.35 % | -19.87 % | -9.94 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | -6.94 % | 3.93 % |
|
5 yr average Debt to Equity
|
0.49 | -3.0 | 17.42 |
|
5yr CAGR Net Profit
|
n/a | -15.97 % | n/a |
|
5yr Average Return on Assets
|
0.6 % | -18.92 % | -6.43 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 34.0 % | 30.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Norris Medicines
|
Parmax Pharma
|
|---|